Personalized Cancer Diagnosis & Therapy...
Radio-Isotope Therapy of America Foundation is a non-profit charitable organization established in Houston, Texas in 2004. We believe cancer therapy should be targeted to only cancer cells, and should have minimal effect on normal organs, thus RITA research and studies focus on "Personalized Cancer Diagnosis and Therapy". RITA Foundation has initiatives in both clinical and research area to fight against cancer.
Rita Supports For Cancer Treatment
RITA Foundation of Houston announces support for newly authorized investigational trial to treat patients with metastatic Castration Resistant prostate cancer (mCRPC). Actinium (Ac)225-PSMA is a new and innovative Targeted Alpha Therapy (TAT) that is used under FDA authorized Investigational New Drug (IND) application. This clinical trial is currently conducted at Excel Diagnostics and Nuclear Oncology Center in Houston. Metastatic CRPC is one of the most aggressive form of prostate cancer and patients have limited therapeutic options. While there are about 2.2 million men in the United States living with prostate cancer, about 43,000 men suffer from this terminal condition. Prostate cancer is the 2nd most common cause of cancer death in men, in the United States. We are hopeful that our support will bring new and effective treatments for this catastrophic illness.Recruitment of patients has started on the above treatment. For further information please contact Mrs. Susan Cork at : firstname.lastname@example.org or call: 713-341-3203.
Click Here To Learn More About "Metastatic Castration Resistant Prostate Cancer" Treatment
RITA is the sponsor of two new Investigational New Drug applications approved by FDA for treatment of neuroendocrine cancers.
RITA Foundation also sponsors Novel Basic Research projects involving labeling novel biochemical agents with therapeutic radioactive materials to create compounds for diagnosis and therapy of cancer.
RITA is the first free standing, nonprofit organization in Houston to offer Digital Mammography for screening BREAST CANCER in women. This imaging modality has significantly higher resolution and can diagnose cancer at a very early stage, with much lower radiation compared to analog mammography.
RITA Foundation also offers high resolution CT-64 slice scan of the lungs for early diagnosis of lung cancer.